The CSRC has not approved U.S. IPOs since April despite a small-cap listing rebound earlier; New arbitration rules emphasize party consent, tribunal independence, and risk management in AI use; and Record-high investments in Belt and Road Initiative driven by strategic sectors.
Capital Markets
- July 24, 2025
Shanghai Stock Exchange sets forth simplified review procedures for offering shares to purchase assets / CLP Reference: 3700/25.05.16 / Issued: 2025-05-16
June 30, 2025CSRC allows for simplified review procedures for offering shares to purchase assets / CLP Reference: 3700/25.05.16 ; Promulgated: 2025-05-16 ; Effective: 2025-05-16
June 30, 2025U.S. to tighten disclosure obligations of foreign listed companies, targeting China; China to allow local investors to invest more in overseas assets under QDII; and EU issues measures to restrict Chinese medical device manufacturers from accessing public procurement contracts
June 26, 2025Western companies concerned about China's demand for sensitive rare earths information; Irish data regulators target transparency and transfer impact assessment failures in landmark decision; and China's largest insurer plans to raise HK$11.77 billion through convertible bond listing in Frankfurt
June 19, 2025Venture capital firm's Chinese investment to be reviewed by U.S. Treasury; Small-scale M&A on the rise despite trade tensions, sluggish growth; and U.S. Congressmen urge delisting of 25 Chinese groups from U.S. exchanges.
May 22, 2025CSRC exempts state secrets from company disclosure / CLP Reference: 2300/25.04.07 ; Promulgated: 2025-04-07 ; Effective: 2025-07-01
May 19, 2025CATL and Ant Group’s planned listings could break recent HK IPO records; The lowering of U.S. drug prices will impact Chinese drugmakers; and U.S. House passes sanctions bill targeting trade secret theft by China.
May 15, 2025China eases cross-border data transfer restrictions for financial institutions; Trade war prompts plan to open up service sector; and new law firm anti-money laundering regulations to align with international standards
April 25, 2025China’s draft pharmaceutical trial rules aim to balance innovation with drug availability; CAC issues first rules to regulate facial recognition technology; and UBS becomes the 5th wholly foreign-owned securities firm in China.
April 03, 2025







